Item request has been placed!
×
Item request cannot be made.
×
Processing Request
LBA2 Interim efficacy analysis of REGINA, a phase II trial of neoadjuvant regorafenib (Rego), nivolumab (Nivo), and short-course radiotherapy (SCRT) in stage II-III rectal cancer (RC).
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- Author(s): Sclafani, F.1 (AUTHOR); Bregni, G.1 (AUTHOR); Assaf, I.1 (AUTHOR); Puleo, F.2 (AUTHOR); Vergauwe, P.3 (AUTHOR); Prenen, H.4 (AUTHOR); Diaz, M.5 (AUTHOR); Gokburun, Y.6 (AUTHOR); Sanchez, A. Veron7 (AUTHOR); Anthoine, G.8 (AUTHOR); Moretti, L.9 (AUTHOR); Gomez Galdon, M.10 (AUTHOR); Liberale, G.11 (AUTHOR); Martinive, P.9 (AUTHOR); Geboes, K.12 (AUTHOR); Carrasco, J.13 (AUTHOR); van den Eynde, M.14 (AUTHOR); Laethem, J-L. van1 (AUTHOR); Buyse, M.E.15 (AUTHOR); Hendlisz, A.1 (AUTHOR)
- Source:
Annals of Oncology. 2024 Supplement 1, Vol. 35, pS212-S213. 2p.
- Subject Terms:
No Comments.